Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
China · Delayed Price · Currency is CNY 16.85
-0.05 (-0.30%)
Mar 19, 2026, 10:34 AM CST
SHA:603858 Market Cap
SHA:603858 has a market cap or net worth of 17.82 billion as of March 18, 2026. Its market cap has increased by 11.49% in one year.
Market Cap
17.82B
Enterprise Value
19.59B
Revenue
10.96B
Ranking
n/a
PE Ratio
10,719.60
Stock Price
16.85
Market Cap Chart
Since November 18, 2016, SHA:603858's market cap has decreased from 54.86B to 17.82B, a decrease of -67.52%. That is a compound annual growth rate of -11.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 17.94B | 8.76% |
| Dec 31, 2025 | 16.49B | -2.05% |
| Dec 31, 2024 | 16.84B | -10.50% |
| Dec 29, 2023 | 18.81B | -19.04% |
| Dec 30, 2022 | 23.24B | -0.38% |
| Dec 31, 2021 | 23.33B | -8.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 20.29B |
| Walvax Biotechnology | 19.64B |
| Wedge Industrial | 19.16B |
| China Resources Double-Crane Pharmaceutical | 18.83B |
| Betta Pharmaceuticals | 18.36B |
| Fujian Cosunter Pharmaceutical | 17.81B |
| Tonghua Dongbao Pharmaceutical | 17.43B |
| Hybio Pharmaceutical | 16.13B |